Cargando…
The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
OBJECTIVE: Alanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD. METHODS: We conducted a retrospective...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505795/ https://www.ncbi.nlm.nih.gov/pubmed/37727457 http://dx.doi.org/10.3389/fendo.2023.1239398 |
_version_ | 1785106980913807360 |
---|---|
author | Qiu, Jiajun Kuang, Maobin Yang, Ruijuan Yu, Changhui He, Shiming Sheng, Guotai Zou, Yang |
author_facet | Qiu, Jiajun Kuang, Maobin Yang, Ruijuan Yu, Changhui He, Shiming Sheng, Guotai Zou, Yang |
author_sort | Qiu, Jiajun |
collection | PubMed |
description | OBJECTIVE: Alanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD. METHODS: We conducted a retrospective analysis of data from 14,251 individuals participating in the NAGALA project’s health screening program. The presence of NAFLD was diagnosed based on the participants’ alcohol consumption status and liver ultrasonography images. Multivariable logistic regression models were used to assess the association between the ALT/HDL-C ratio and NAFLD. Receiver operating characteristic (ROC) analysis was performed to determine and compare the effectiveness of ALT, HDL-C, the aspartate aminotransferase to HDL-C (AST/HDL-C) ratio, the gamma-glutamyl transferase to HDL-C (GGT/HDL-C) ratio and the ALT/HDL-C ratio in identifying NAFLD. RESULTS: We observed a significant positive association between the ALT/HDL-C ratio and the prevalence of NAFLD. For each standard deviation (SD) increase in the ALT/HDL-C ratio, the adjusted odds ratio (OR) for NAFLD among the participants was 3.05 [95% confidence interval (CI): 2.63, 3.53], with the highest quartile of ALT/HDL-C ratio having a 9.96-fold increased risk compared to the lowest quartile. In further subgroup analyses stratified by gender, age, and waist circumference (WC), we observed a significantly higher risk of NAFLD associated with the ALT/HDL-C ratio among individuals aged ≥45 years, males, and those who were abdominal obesity. Furthermore, based on the results of ROC analysis, we found that the ALT/HDL-C ratio [area under the curves (AUC): 0.8553] was significantly superior to ALT, HDL-C, AST/HDL-C ratio and GGT/HDL-C ratio in identifying NAFLD (All Delong P<0.05); the threshold of suggested ALT/HDL-C ratio for identifying NAFLD was 15.97. CONCLUSION: This population-based study demonstrates a positive association between the ALT/HDL-C ratio and NAFLD. The ALT/HDL-C ratio can effectively identify individuals with NAFLD. |
format | Online Article Text |
id | pubmed-10505795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105057952023-09-19 The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease Qiu, Jiajun Kuang, Maobin Yang, Ruijuan Yu, Changhui He, Shiming Sheng, Guotai Zou, Yang Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Alanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD. METHODS: We conducted a retrospective analysis of data from 14,251 individuals participating in the NAGALA project’s health screening program. The presence of NAFLD was diagnosed based on the participants’ alcohol consumption status and liver ultrasonography images. Multivariable logistic regression models were used to assess the association between the ALT/HDL-C ratio and NAFLD. Receiver operating characteristic (ROC) analysis was performed to determine and compare the effectiveness of ALT, HDL-C, the aspartate aminotransferase to HDL-C (AST/HDL-C) ratio, the gamma-glutamyl transferase to HDL-C (GGT/HDL-C) ratio and the ALT/HDL-C ratio in identifying NAFLD. RESULTS: We observed a significant positive association between the ALT/HDL-C ratio and the prevalence of NAFLD. For each standard deviation (SD) increase in the ALT/HDL-C ratio, the adjusted odds ratio (OR) for NAFLD among the participants was 3.05 [95% confidence interval (CI): 2.63, 3.53], with the highest quartile of ALT/HDL-C ratio having a 9.96-fold increased risk compared to the lowest quartile. In further subgroup analyses stratified by gender, age, and waist circumference (WC), we observed a significantly higher risk of NAFLD associated with the ALT/HDL-C ratio among individuals aged ≥45 years, males, and those who were abdominal obesity. Furthermore, based on the results of ROC analysis, we found that the ALT/HDL-C ratio [area under the curves (AUC): 0.8553] was significantly superior to ALT, HDL-C, AST/HDL-C ratio and GGT/HDL-C ratio in identifying NAFLD (All Delong P<0.05); the threshold of suggested ALT/HDL-C ratio for identifying NAFLD was 15.97. CONCLUSION: This population-based study demonstrates a positive association between the ALT/HDL-C ratio and NAFLD. The ALT/HDL-C ratio can effectively identify individuals with NAFLD. Frontiers Media S.A. 2023-08-31 /pmc/articles/PMC10505795/ /pubmed/37727457 http://dx.doi.org/10.3389/fendo.2023.1239398 Text en Copyright © 2023 Qiu, Kuang, Yang, Yu, He, Sheng and Zou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Qiu, Jiajun Kuang, Maobin Yang, Ruijuan Yu, Changhui He, Shiming Sheng, Guotai Zou, Yang The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_full | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_fullStr | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_full_unstemmed | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_short | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_sort | newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505795/ https://www.ncbi.nlm.nih.gov/pubmed/37727457 http://dx.doi.org/10.3389/fendo.2023.1239398 |
work_keys_str_mv | AT qiujiajun thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT kuangmaobin thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT yangruijuan thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT yuchanghui thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT heshiming thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT shengguotai thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT zouyang thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT qiujiajun newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT kuangmaobin newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT yangruijuan newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT yuchanghui newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT heshiming newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT shengguotai newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT zouyang newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease |